Surgery Partners/SGRY

$25.83

-2.34%
-
1D1W1MYTD1YMAX

About Surgery Partners

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Its segments include Surgical Facility Services and Ancillary Services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology and general surgery. The Ancillary Services segment consisted of multi-specialty physician practices, including physician practices owned and operated pursuant to long-term management service agreements. It is focused on surgical services businesses in the United States, with over 180 locations in 33 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices.

Ticker

SGRY

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Wayne Deveydt

Employees

10,500

Headquarters

Brentwood, United States

Surgery Partners Metrics

BasicAdvanced
$3.4B
Market cap
8904.60
P/E ratio
$0.00
EPS
2.72
Beta
-
Dividend rate
$3.4B
2.71762
$45.79
$22.05
980K
1.712
1.565
142.012
145.936
39.375
2.47%
2.33%
0.03%
3.2%
8,904.605
1.231
1.749
19.716
7.1%
100.33%
13.83%

What the Analysts think about Surgery Partners

Analyst Ratings

Majority rating from 11 analysts.
Buy

Price Targets

Average projection from 11 analysts.
59.08% upside
High $50.00
Low $35.00
$25.83
Current price
$41.09
Average price target

Surgery Partners Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1.72% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$717M
-2.45%
Net income
-$12M
1,140%
Profit margin
-1.72%
1,223.08%

Surgery Partners Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 39.77%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.28
$0.19
$0.44
$0.10
-
Expected
$0.08
$0.16
$0.38
$0.07
$0.20
Surprise
245.29%
16.49%
16.16%
39.77%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Surgery Partners stock?

Surgery Partners (SGRY) has a market cap of $3.3B as of May 20, 2024.

What is the P/E ratio for Surgery Partners stock?

The price to earnings (P/E) ratio for Surgery Partners (SGRY) stock is 8496.71 as of May 20, 2024.

Does Surgery Partners stock pay dividends?

No, Surgery Partners (SGRY) stock does not pay dividends to its shareholders as of May 20, 2024.

When is the next Surgery Partners dividend payment date?

Surgery Partners (SGRY) stock does not pay dividends to its shareholders.

What is the beta indicator for Surgery Partners?

Surgery Partners (SGRY) has a beta rating of 2.71. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Surgery Partners stock price target?

The target price for Surgery Partners (SGRY) stock is $41.09, which is 59.08% above the current price of $25.83. This is an average based on projections from 11 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Surgery Partners stock

Buy or sell Surgery Partners stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing